A Study to Evaluate the Efficacy of ALMB-0168 in Solid Tumor Patients With Bone Metastatic Whose Prior Standard Treatment Have Failed
Clinical trial NCT06416358 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06416358
- Sponsor
- AlaMab Therapeutics (Shanghai) Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-06-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.